The robotics company reduced its 2026 cash burn forecast and said its development timeline remains on track, with a system design freeze expected by year-end.
Vicarious Surgical applies for Nasdaq listing
The robotics company reduced its 2026 cash burn forecast and said its development timeline remains on track, with a system design freeze expected by year-end.